MELISSA CLARK: Open Payments
NPI 1639681000 · CONCORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 26 payments from 6 companies in 2025. Trend: 2023 $303 · 2024 $528 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $198 |
| Fresenius USA Marketing, Inc. | 8 | $146 |
| Ardelyx, Inc. | 3 | $142 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: KRYSTEXXA, VELPHORO, XPHOZAH 30 MG, FARXIGA, Kerendia, IBSRELA, Fabhalta.
Industry payments across CA — which companies pay providers there.
